Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference30 articles.
1. Acorda Therapeutics (2018) Inbrija® (levodopa inhalation powder): US prescribing information. 2018. https://www.inbrija.com/. Accessed 4 Apr 2020.
2. Chou KL, Stacy M, Simuni T, Miyasaki J, Oertel WH, Sethi K, Fernandez HH, Stocchi F (2018) The spectrum of “off” in Parkinson’s disease: What have we learned over 40 years? Parkinsonism Relat Disord 51:9–16. https://doi.org/10.1016/j.parkreldis.2018.02.001
3. Dewey RB, Hutton JT, LeWitt PA, Factor SA (2001) A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events. Arch Neurol 58:1385–1392. https://doi.org/10.1001/archneur.58.9.1385
4. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R (1997) Large porous particles for pulmonary drug delivery. Science 276(5320):1868–1871. https://doi.org/10.1126/science.276.5320.1868
5. European Medicines Agency (2019) Inbrija® (levodopa inhalation powder): EU summary of product characteristics. 2019. https ://www.ema.europa.eu/. Accessed 18 Jan 2022.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献